In this issue:
New Issues in the Challenge of HIV Drug Resistance
pp. 737-740.
Three-Class Antiretroviral Resistance in a Patient with Acute HIV-1
pp. 741-744. Abstract
Successful Treatment with Atazanavir and Lopinavir/Ritonavir Combination Therapy in Protease Inhibitor-Susceptible and Protease Inhibitor-Resistant HIV-Infected Patients
pp. 745-759. Abstract
A Comprehensive Evaluation of Survey Questions for Adherence to Antiretroviral Medications and Exploratory Analyses for Identifying Optimal Sets of Survey Questions
pp. 760-772. Abstract
A Randomized Trial of the Impact of a Programmable Medication Reminder Device on Quality of Life in Patients with
pp. 773-781. Abstract
Association of Comorbidity with Physical Disability in Older HIV-Infected Adults
pp. 782-791. Abstract
The Intent and Practice of Condom Use Among HIV-Positive Men Who Have Sex with Men in Japan
pp. 792-802. Abstract
HIV-Related Knowledge, Attitudes, Perceived Benefits, and Risks of HIV Testing Among Pregnant Women in Rural Southern India
pp. 803-811. Abstract
Antiviral Briefs
pp. 812-813.
Drug Developments and STD News
pp. 814-816.
Thursday, December 21, 2006
Tuesday, December 19, 2006
New article published in Harm Reduction Journal
HIV seroprevalence among participants at a medically supervised injection facility in Vancouver, Canada: Implications for prevention, care and treatment.
Abstract:
North Americas first government sanctioned medically supervised injection facility (SIF) was opened during September 2003 in Vancouver, Canada. This was in response to a large open public drug scene, high rates of HIV and hepatitis C transmission, fatal drug overdoses, and poor health outcomes among the citys injection drug users. Between December 2003 and April 2005, a representative sample of 1,035 SIF participants were enrolled in a prospective cohort that required completing an interviewer-administered questionnaire and providing a blood sample for HIV testing. HIV infection was detected in 170/1007 (17%) participants and was associated with Aboriginal ethnicity (adjusted Odds Ratio [aOR], 2.70, 95% Confidence Interval [95% CI], 1.84-3.97), a history of borrowing used needles/syringes (aOR, 2.0, 95% CI, 1.37-2.93), previous incarceration (aOR, 1.87, 95% CI, 1.11-3.14), and daily injection cocaine use (aOR, 1.42, 95% CI, 1.00-2.03). The SIF has attracted a large number of marginalized injection drug users and presents an excellent opportunity to enhance HIV prevention through education, the provision of sterile injecting equipment, and a supervised environment to self-inject. In addition, the SIF is an important point of contact for HIV positive individuals who may not be participating in HIV care and treatment.
Click here to read the article.
Abstract:
North Americas first government sanctioned medically supervised injection facility (SIF) was opened during September 2003 in Vancouver, Canada. This was in response to a large open public drug scene, high rates of HIV and hepatitis C transmission, fatal drug overdoses, and poor health outcomes among the citys injection drug users. Between December 2003 and April 2005, a representative sample of 1,035 SIF participants were enrolled in a prospective cohort that required completing an interviewer-administered questionnaire and providing a blood sample for HIV testing. HIV infection was detected in 170/1007 (17%) participants and was associated with Aboriginal ethnicity (adjusted Odds Ratio [aOR], 2.70, 95% Confidence Interval [95% CI], 1.84-3.97), a history of borrowing used needles/syringes (aOR, 2.0, 95% CI, 1.37-2.93), previous incarceration (aOR, 1.87, 95% CI, 1.11-3.14), and daily injection cocaine use (aOR, 1.42, 95% CI, 1.00-2.03). The SIF has attracted a large number of marginalized injection drug users and presents an excellent opportunity to enhance HIV prevention through education, the provision of sterile injecting equipment, and a supervised environment to self-inject. In addition, the SIF is an important point of contact for HIV positive individuals who may not be participating in HIV care and treatment.
Click here to read the article.
Monday, December 18, 2006
Launch of CONNECT: Canadian HIV/AIDS Information Gateway
CONNECT is a union catalogue. You can use this catalogue to search the library collections of the five largest HIV/AIDS libraries in Canada. That represents a combined collection of over 67 000 books, videos, DVDs, journal articles, and other resources on HIV/AIDS prevention, treatment, and legal/ethical issues, among many other topics.CONNECT is a Canadian partnership between community-based HIV/AIDS organizations:
- AIDS Committee of Toronto
- AIDS Vancouver
- Canadian AIDS Treatment Information Exchange
- Canadian HIV/AIDS Information Centre
- Canadian HIV/AIDS Legal Network
Visit us at http://www.hivinfovih.ca/ !!!
Subscribe to:
Posts (Atom)
